Efficacy of a murine-p75-saporin immunotoxin for selective lesions of basal forebrain cholinergic neurons in mice

Neuroscience Letters

Volumn 452, Issue 3, 2009, Pages 247-251

  Nag, Nupur ^a   Baxter, Mark G ^b   Berger Sweeney, Joanne E ^a  

^a WELLESLEY COLLEGE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetylcholine; Anxiety; Choline acetyltransferase; Locomotor; Neurodegenerative disease; Parvalbumin

Indexed keywords

NEUROTROPHIN RECEPTOR P75; SAPORIN;

ANIMAL CELL; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOREBRAIN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ANXIETY; BASAL NUCLEUS OF MEYNERT; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOTOXINS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MORTALITY; MOTOR ACTIVITY; NEURONS; RECEPTORS, NERVE GROWTH FACTOR; RIBOSOME INACTIVATING PROTEINS, TYPE 1; SEPTUM OF BRAIN;

EID: 60849137822     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.01.006     Document Type: Article

References (26)

1. Bartus R.T., Dean III R.L., Pontecorvo M.J., and Flicker C. The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann. N Y Acad. Sci. 444 (1985) 332-358
2. Baxter M.G. Effects of selective immunotoxic lesions on learning and memory. In: Hall W.A. (Ed). Methods in Molecular Biology. Immunotoxin Methods and Protocols vol. 166 (2001), Humana Press, Totowa, NJ 249-265
3. Baxter M.G., Bucci D.J., Gorman L.K., Wiley R.G., and Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurosci. 109 (1995) 714-722
4. Berger-Sweeney J. The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers. Neurosci. Biobehav. Rev. 27 (2003) 401-411
5. Berger-Sweeney J., Heckers S., Mesulam M.-M., Wiley R.G., Lappi D.A., and Sharma M. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 14 (1994) 4507-4519
6. Berger-Sweeney J., Stearns N.A., Murg S.L., Floerke-Nashner L.R., Lappi D.A., and Baxter M.G. Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior. J. Neurosci. 21 (2001) 8164-8173
7. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., and Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64 (1995) 749-760
8. Cook M.N., Williams R.W., and Flaherty L. Anxiety-related behaviors in the elevated zero-maze are affected by genetic factors and retinal degeneration. Behav. Neurosci. 115 (2001) 468-476
9. Heckers S., Ohtake T., Wiley R.G., Lappi D.A., Geula C., and Mesulam M.-M. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14 (1994) 1271-1289
10. Hunter C.L., Bachman D., and Granholm A.C. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann. Neurol. 56 (2004) 675-688
11. Hunter C.L., Quintero E.M., Gilstrap L., Bhat N.R., and Granholm A.C. Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur. J. Neurosci. 19 (2004) 3305-3316
12. Kiss J., Patel A.J., Baimbridge K.G., and Freund T.F. Topographical localization of neurons containing parvalbumin and choline acetyltransferase in the medial septum-diagonal band region of the rat. Neuroscience 36 (1990) 61-72
13. McGaughy J., Everitt B.J., Robbins T.W., and Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav. Brain Res. 115 (2000) 251-263
14. McGeer E.G., Norman M., Boyes B., O'Kusky J., Suzuki J., and McGeer P.L. Acetylcholine and aromatic amine systems in postmortem brain of an infant with Down's syndrome. Exp. Neurol. 87 (1985) 557-570
15. Moreau P.H., Cosquer B., Jeltsch H., Cassel J.C., and Mathis C. Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus 18 (2008) 610-622
16. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. (2001), Academic Press, San Diego
17. Sarter M., Bruno J.P., Miner L.A.H., and McGaughy J. Development of a method for intraparenchymal infusions of 192 IgG-saporin: a comment on Pizzo et al. (1999). J. Neurosci. Methods 96 (2000) 169-170
18. Torres E.M., Perry T.A., Blokland A., Wilkinson L.S., Wiley R.G., Lappi D.A., and Dunnett S.B. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 63 (1994) 95-122
19. Vuckovich J.A., Semel M.E., and Baxter M.G. Extensive lesions of cholinergic basal forebrain neurons do not impair spatial working memory. Learn. Mem. 11 (2004) 87-94
20. Waite J.J., Wardlow M.L., Chen A.C., Lappi D.A., Wiley R.G., and Thal L.J. Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin. Neurosci. Lett. 169 (1994) 154-158
21. Waite J.J., Wardlow M.L., and Power A.E. Deficit in selective and divided attention associated with cholinergic basal forebrain immunotoxic lesion produced by 192-saporin; motoric/sensory deficit associated with Purkinje cell immunotoxic lesion produced by OX7-saporin. Neurobiol. Learn. Mem. 71 (1999) 325-352
22. Wenk G.L. Rett syndrome: neurobiological changes underlying specific symptoms. Prog. Neurobiol. 51 (1997) 383-391
23. Wenk G.L., Stoehr J.D., Quintana G., Mobley S., and Wiley R.G. Behavioral, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14 (1994) 5986-5995
24. Wiley R.G. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci. 15 (1992) 285-290
25. Wrenn C.C., Lappi D.A., and Wiley R.G. Threshold relationship between lesion extent of the cholinergic basal forebrain in the rat and working memory impairment in the radial maze. Brain Res. 847 (1999) 284-298
26. Wrenn C.C., and Wiley R.G. Lack of effect of moderate Purkinje cell loss on working memory. Neuroscience 107 (2001) 433-445